Henry Meds Pricing: Medication Cost and Monthly Plans Compared 2026

Last reviewed: September 7, 2026 Last updated: September 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Henry Meds offers multiple GLP-1 medications at different price points, each with its own commitment structure. Injectable compounded semaglutide costs $297/month on a month-to-month basis or $197/month paid-in-full for 12 months ($2,364 upfront). Oral semaglutide tablets cost $249/month month-to-month or $149/month paid-in-full for 12 months ($1,788 upfront). Liraglutide starts at $179/month month-to-month, and oral tirzepatide costs $297/month equivalent ($891 paid-in-full for three months, the only term available). Henry includes medication, provider visits, shipping, and supplies in all pricing; there is no separate membership fee. PlexusDx injectable semaglutide costs $189/month month-to-month or $149/month on a six-month plan ($894 total), delivering a $1,296/year advantage over Henry's month-to-month injectable semaglutide rate. For oral semaglutide, Henry's month-to-month rate is $40/month less than PlexusDx ($249 vs $289). Buyers considering Henry's prepaid plans should understand that canceling a multi-month plan requires paying the remaining balance unless a medical reason applies, and readers should confirm all pricing at checkout because Henry's website displays internal inconsistencies for some products.

At a glance: Henry Meds pricing by medication

*Henry's website displays an internal inconsistency for oral tirzepatide: the legal-programs page states delivery every 60 days for six months, while the product heading describes a three-month supply. Confirm the term and refill schedule at checkout. Henry does not offer injectable tirzepatide.

What Henry Meds pricing includes—and what it doesn't

Henry Meds advertises all-inclusive pricing: each rate covers medication, provider visits, shipping, and supplies. There is no separate membership fee. Pricing is verified from Henry's website as of July and September 2026.

Henry offers injectable semaglutide on three terms: month-to-month at $297/month, six-month prepaid at $1,482 total ($247/month equivalent), and 12-month prepaid at $2,364 total ($197/month equivalent). Oral semaglutide tablets cost $249/month month-to-month, $1,014 for six months prepaid ($169/month equivalent), or $1,788 for 12 months prepaid ($149/month equivalent). Oral microdose semaglutide (labeled "Premium" tablets or drops) costs $179/month for the first month, then $169/month refill rate, and shares the same prepaid pricing as standard oral tablets. Liraglutide injection starts at $179/month month-to-month, with a 12-month prepaid option at $1,428 total ($119/month equivalent). Oral tirzepatide is available only as a three-month prepaid supply for $891 ($297/month equivalent); Henry does not offer injectable tirzepatide.

Henry states that members can cancel at any time through the patient portal, by email at ask@henrymeds.com, or by phone at 909-787-2342. If you are on a multi-month prepaid plan, you may be required to pay the remaining balance unless you are unable to continue for medical reasons as determined by a healthcare provider. This policy means that prepaid savings are realized only if you complete the full commitment or qualify for a medical exception.

Henry Meds vs. PlexusDx: normalized 12-month pricing

We calculate the true 12-month cost for each program to compare like-for-like. All figures are our calculation unless stated otherwise.

Injectable compounded semaglutide

PlexusDx month-to-month vs. Henry month-to-month: PlexusDx costs $1,296 less per year ($2,268 vs. $3,564). PlexusDx six-month prepaid vs. Henry 12-month prepaid: PlexusDx costs $576 less per year ($1,788 vs. $2,364), with half the upfront commitment ($894 every six months vs. $2,364 once).

Oral semaglutide

Henry month-to-month vs. PlexusDx month-to-month: Henry costs $480 less per year for oral semaglutide ($2,988 vs. $3,468).

Decision factors: strengths and gaps

Henry Meds strengths

• Transparent all-inclusive pricing: No membership fees, no per-visit charges, no surprise costs.
• Wider medication menu: Injectable semaglutide, oral semaglutide, oral tirzepatide, liraglutide, and oral microdose options all available through one platform.
• Deep prepaid discounts: 12-month injectable semaglutide prepaid drops to $197/month equivalent (from $297/month), and oral semaglutide prepaid drops to $149/month equivalent (from $249/month).
• Strong Trustpilot rating: 4.4 stars across approximately 13,000 reviews, captured September 2026.
• Free evaluation: No charge unless a provider issues a prescription.

Henry Meds gaps and cautions

• Prepaid commitment required for lowest rates: The widely advertised rates require full upfront payment and remain binding unless a medical reason qualifies you for early exit.
• Month-to-month injectable semaglutide is $108/month more expensive than PlexusDx: $297 vs. $189.
• Internal pricing inconsistencies: Henry's website displays conflicting information for oral tirzepatide (three-month supply vs. six-month term) and oral semaglutide three-month pricing. Confirm the exact term and refill schedule at checkout.
• No injectable tirzepatide: Only oral tirzepatide is offered, which may not suit members who prefer or require injection administration.
• California fulfillment delays: Henry notes that California residents may experience increased wait times due to additional compound testing requirements.

PlexusDx strengths

• Lower month-to-month injectable semaglutide rate: $189/month with no prepayment required, a $1,296/year advantage over Henry's month-to-month rate.
• Six-month prepaid delivers $149/month equivalent with lower upfront commitment: $894 every six months vs. $2,364 once for Henry's 12-month plan.
• Tirzepatide injection available: $289/month month-to-month or $249/month on a six-month plan; Henry does not offer this route.
• Microdose GLP-1 for maintenance: $129/month month-to-month, a practical step-down option for members transitioning off higher doses.
• Trustpilot rating: 4.3 stars, with 79 percent of reviews at five stars and 83 percent at four stars or higher, captured September 2026.

PlexusDx gaps

• Oral semaglutide costs $40/month more than Henry month-to-month: $289 vs. $249.
• No liraglutide or oral tirzepatide: PlexusDx does not offer these alternatives.
• No 12-month injectable semaglutide term: The longest commitment is six months; Henry offers a 12-month prepaid option at $197/month equivalent.

Choose Henry Meds if…

• You prefer oral semaglutide and want the lowest month-to-month rate without multi-month commitment ($249 vs. $289 at PlexusDx).
• You want oral tirzepatide and accept the three-month prepaid requirement ($891 total, $297/month equivalent).
• You are comfortable prepaying for 12 months of injectable semaglutide to access the $197/month equivalent rate, and your medical and financial circumstances make completing the full term realistic.
• You are considering liraglutide as a first-line GLP-1 medication and want a platform that offers it alongside other options.
• You value a single platform with a wide medication menu and are willing to navigate internal website inconsistencies by confirming details directly with support before purchase.

Choose PlexusDx if…

• You prefer injectable semaglutide and want the lowest month-to-month rate available ($189 vs. $297 at Henry).
• You want a prepaid discount with lower upfront risk: PlexusDx six-month injectable semaglutide costs $894 every six months ($149/month equivalent) vs. Henry's 12-month $2,364 one-time charge ($197/month equivalent).
• You want injectable tirzepatide, which Henry does not offer; PlexusDx charges $289/month month-to-month or $249/month on a six-month plan.
• You are planning a step-down to maintenance therapy and want a dedicated microdose GLP-1 option at $129/month.
• You value transparent pricing with no internal inconsistencies and want to avoid the risk of website conflicts at checkout.

Understanding Henry's advertised starting price

Henry advertises a starting price in consumer-facing materials. This figure applies to liraglutide or oral microdose semaglutide on a month-to-month basis, not injectable semaglutide. Injectable semaglutide starts at $297/month month-to-month or $247/month equivalent on a six-month prepaid plan. Readers comparing providers should confirm which medication and term each advertised starting price represents before making a decision.

Eligibility, process, and timelines

Henry Meds offers a free evaluation with no charge unless a provider issues a prescription. Eligibility is limited to adults aged 18 to 70 for GLP-1 treatment. Most members receive medication within 8 to 10 business days after the provider consultation. Refills ship every 45 days for injectables or every 90 days for oral tablets. California residents may experience longer fulfillment times due to additional compound testing mandated by state regulations.

Methodology and freshness

We captured Henry Meds pricing from the company's website on July 20, 2026, and September 4, 2026, and confirmed all-inclusive terms from FAQ and legal-programs pages on September 7, 2026. We captured PlexusDx pricing from live product pages on July 20, 2026, and September 7, 2026. We flagged two internal inconsistencies on Henry's website: the oral tirzepatide legal-programs page states delivery every 60 days for six months, while the product heading describes a three-month supply; and the oral semaglutide three-month pricing page contains an internal labeling error referencing tirzepatide. We advise readers to confirm medication, term, and refill schedule at checkout. All 12-month cost calculations are our own and assume continuous enrollment with no dose changes, early exits, or medical exceptions. Trustpilot ratings for both providers were captured September 4, 2026.

Frequently Asked Questions

Does Henry Meds charge a membership fee on top of medication cost?

No. Henry Meds advertises all-inclusive pricing: the monthly rate covers medication, provider visits, shipping, and supplies. There is no separate membership fee. This structure applies to all Henry medications, including injectable semaglutide, oral semaglutide, oral tirzepatide, liraglutide, and microdose options.

Can I cancel a Henry Meds prepaid plan early without penalty?

You can cancel through the patient portal, by email, or by phone at any time. However, if you are on a multi-month prepaid plan, Henry states you may be required to pay the remaining balance unless you are unable to continue for medical reasons as determined by a healthcare provider. This policy means prepaid savings are realized only if you complete the full term or qualify for a medical exception.

Does Henry Meds offer injectable tirzepatide?

No. Henry Meds offers only oral tirzepatide in a dissolving-tablet form, priced at $891 for a three-month supply ($297/month equivalent, paid-in-full). Injectable tirzepatide is not available through Henry. PlexusDx offers injectable tirzepatide at $289/month month-to-month or $249/month on a six-month plan.

Why does Henry's website show conflicting information for some medications?

We observed two internal inconsistencies during our September 2026 capture: the oral tirzepatide legal-programs page states delivery every 60 days for six months, while the product heading describes a three-month supply; and the oral semaglutide three-month pricing page contains a labeling error referencing tirzepatide. We recommend confirming the exact medication, term, refill schedule, and total cost with Henry support before finalizing your purchase.

How much do I save with PlexusDx month-to-month injectable semaglutide compared to Henry?

PlexusDx injectable semaglutide costs $189/month month-to-month vs. Henry's $297/month, a difference of $108/month or $1,296/year (our calculation). PlexusDx also offers a six-month prepaid plan at $149/month equivalent ($894 total every six months), which costs $576 less per year than Henry's 12-month prepaid rate of $197/month equivalent ($2,364 paid-in-full), with half the upfront commitment.

Sources

• Henry Meds website, pricing pages for injectable semaglutide, oral semaglutide, oral tirzepatide, liraglutide, and microdose semaglutide (accessed July 20, 2026, and September 4, 2026)
• Henry Meds FAQ and legal-programs pages for all-inclusive pricing, cancellation policy, eligibility, fulfillment timelines, and California notice (accessed September 7, 2026)
• PlexusDx product pages for injectable semaglutide, oral semaglutide, injectable tirzepatide, and microdose GLP-1 (accessed July 20, 2026, and September 7, 2026)
• Trustpilot ratings for Henry Meds and PlexusDx (accessed September 4, 2026)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.